We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
How a product complies with EU safety, health and environmental requirements, and how to place a CE marking on your product.
How to use an interrupted time series to evaluate your digital health product.
How to create a model of how your digital health product works and choose measures for your evaluation.
How to use a quasi-experimental study to evaluate your digital health product.
Answers to frequently asked questions on Approved Document B including 2020 and 2022 amendments.
How to use a cost benefit analysis to evaluate your digital health product.
How to use routinely collected data to evaluate your digital health product.
Things to consider when buying and using products.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Apply for changes to your marketing authorisation, including minor variations type IA and IB, major variations type II and extensions.
Recall alert for Johnson’s 4Fleas 11.4 mg Tablets for Cats and Kittens 6-tablet pack for incorrect packaging relating to 4Fleas Tablets for Dogs 6-tablet pack.
How to use Union Transit to move non-EU goods within the UK or EU, and to move goods to or from the special territories.
How to use a before-and-after study to evaluate your digital health product.
How to use a combination of quantitative and qualitative data to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
Using an ecological momentary assessment to evaluate your digital health product.
Guidance for suppliers and dealers.
Ensuring you get what you pay for.
How to use an economic evaluation to evaluate your digital health product.
Substances that are classed as persistent organic pollutants (POPs) and when you're allowed to use them.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).